We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01724671
Recruitment Status : Unknown
Verified November 2012 by Jerome Schentag, CPL Associates.
Recruitment status was:  Not yet recruiting
First Posted : November 12, 2012
Last Update Posted : November 12, 2012
Forest Laboratories
Information provided by (Responsible Party):
Jerome Schentag, CPL Associates

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2013
  Estimated Study Completion Date : December 2013